BMJ Best Practice

参考文献

关键文献

Tannous ZS, Mihm MC Jr, Sober AJ, et al. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52:197-203.

Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr. 2007;19:430-440.

Ackerman AB. "Dysplastic nevus" syndrome: does a survey make it real? J Am Acad Dermatol. 2003;48:461-463.

Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008;128:2365-2380.

Koh HK. Cutaneous melanoma. N Engl J Med. 1991;325:171-182.

Larsen F, Cockerell CJ. The dysplastic nevus concept. Pathology Case Rev. 2007;12:240-244.

Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20:617-628.

Campos-do-Carmo G, Ramos-e-Silva M. Dermatoscopy: basic concepts. Int J Dermatol. 2008;47:712-719.

Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012;67:1.e1-1.e16.

Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part II. Molecular aspects and clinical management. J Am Acad Dermatol. 2012;67:19.e1-19.e12.

Zalaudek I, Docimo G, Argenziano G. Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol. 2009;145:816-826.

参考文章

1.  McKee PH, Calonje E, Granter SR, eds. Pathology of the skin. 3rd ed. London: Elsevier; 2005.

2.  Argenziano G, Zalaudek I, Ferrara G, et al. Proposal of a new classification system for melanocytic naevi. Br J Dermatol. 2007;157:217-227.

3.  Schmoeckel, C. Classification of melanocytic nevi: do nodular and flat nevi develop differently? Am J Dermatopathol. 1997;19:31-34.

4.  Burkhart CG. Dysplastic nevi. N Engl J Med. 2004;350:1258-1259.

5.  Bolognia JL, Jorizzo JL, Rapini RP, et al. Dermatology. 2nd ed. New York, NY: Mosby; 2008.

6.  Tannous ZS, Mihm MC Jr, Sober AJ, et al. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52:197-203.

7.  Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr. 2007;19:430-440.

8.  Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of nevi in 5- to 6- year-old European children. J Clin Epidemiol. 2002;55:1075-1081.

9.  Maize JC, Foster G. Age-related changes in melanocytic naevi. Clin Exp Dermatol. 1979;4:49-58.

10.  Coleman WP 3rd, Gately LE 3rd, Krementz AB, et al. Nevi, lentigines, and melanoma in blacks. Arch Dermatol. 1980;116:548-551.

11.  Gallagher RP, Rivers JK, Lee TK, et al. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA. 2000;283:2955-2960.

12.  Warner PM, Yakuboff KP, Kagan RJ, et al. An 18-year experience in the management of congenital nevomelanocytic nevi. Ann Plast Surg. 2008;60:283-287.

13.  Ackerman AB. "Dysplastic nevus" syndrome: does a survey make it real? J Am Acad Dermatol. 2003;48:461-463.

14.  Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania. Arch Dermatol. 2005;141:579-586.

15.  Wachsmuth RC, Turner F, Barrett JH, et al. The effect of sun exposure in determining nevus density in UK adolescent twins. J Invest Dermatol. 2005;214:56-62.

16.  Rivers JK, Maclennan R, Kelly JW, et al. The eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol. 1995;32:957-963.

17.  Gallagher RP, McLean DI. The epidemiology of acquired melanocytic nevi: a brief review. Dermatol Clin. 1995;13:595-603.

18.  Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008;128:2365-2380.

19.  Burkhart CG, Burkhart CN. The mole theory: primary function of melanocytes and melanin may be antimicrobial defense and immunomodulation (not solar protection). Int J Dermatol. 2005;44:340-342.

20.  Koh HK. Cutaneous melanoma. N Engl J Med. 1991;325:171-182.

21.  Harrison SL, MacLennan R, Buettner PG. Sun exposure and the incidence of melanocytic nevi in young Australian children. Cancer Epidemiol Biomarkers Prev. 2008;17:2318-2324.

22.  Kelly JW, Rivers JK, MacLennan R, et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol. 1994;30:40-48.

23.  American Academy of Dermatology. Body mole map. http://www.aad.org (last accessed 1 August 2017).

24.  American Melanoma Foundation. ABCD's of melanoma. 2006. http://www.melanomafoundation.org (last accessed 1 August 2017).

25.  Schaffer JV, Orlow SJ, Lazova R, et al. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol. 2001;137:172-178.

26.  Cyr PR. Atypical moles. Am Fam Physician. 2008;78:735-740.

27.  Larsen F, Cockerell CJ. The dysplastic nevus concept. Pathology Case Rev. 2007;12:240-244.

28.  Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20:617-628.

29.  Grob JJ, Bonerandi JJ. The ugly duckling sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134:103-104.

30.  Campos-do-Carmo G, Ramos-e-Silva M. Dermatoscopy: basic concepts. Int J Dermatol. 2008;47:712-719.

31.  Smith L, Macneil S. State of the art in non-invasive imaging of cutaneous melanoma. Skin Res Technol. 2011;17:257-269.

32.  Brehmer F, Ulrich M, Haenssle HA. Strategies for early recognition of cutaneous melanoma - present and future. Dermatol Pract Conc. 2012;2:6.

33.  Walter FM, Morris HC, Humphrys E, et al. Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379]. BMC Fam Pract. 2010;11:36.

34.  Moncrieff M, Cotton S, Claridge E, et al. Spectrophotometric intracutaenous analysis: a new technique for imagining pigmented skin lesions. Br J Dermatol. 2002;146:448-457.

35.  Mackie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermatol. 1991;16:151-153.

36.  Walter FM, Morris HC, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ. 2012;345:e4110.

37.  Elbaum M, Kopf AW, Rabinovitz HS, et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol. 2001;44:207-218.

38.  Bolognia JL. Biopsy techniques for pigmented lesions. Dermatol Surg. 2001;26:89-90.

39.  Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012;67:1.e1-1.e16.

40.  Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part II. Molecular aspects and clinical management. J Am Acad Dermatol. 2012;67:19.e1-19.e12.

41.  Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2009;124(1 Suppl):1e-13e.

42.  Marghoob AA, Kopf AW. Persistent nevus: an exception to the ABCD rule of dermoscopy. J Am Acad Dermatol. 1997;36:474-475.

43.  Kornber R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol. 1975;111:1588-1590.

44.  New Zealand Guidelines Group. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. June 2008. http://www.health.govt.nz (last accessed 1 August 2017).

45.  Strazzula L, Vedak P, Hoang MP, et al. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis. J Am Acad Dermatol. 2014;71:1071-1076.

46.  Reddy KK, Farber MJ, Bhawan J, et al. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma. JAMA Dermatol. 2013;149:928-934.

47.  Abello-Poblete MV, Correa-Selm LM, Giambrone D, et al. Histologic outcomes of excised moderate and severe dysplastic nevi. Dermatol Surg. 2014;40:40-45.

48.  Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013;37:676-684.

49.  Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012;36:808-817.

50.  Tanaka M. Dermoscopy. J Dermatol. 2006;33:513-517.

51.  Zalaudek I, Docimo G, Argenziano G. Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol. 2009;145:816-826.

52.  American Cancer Society. Cancer facts and figures 2008. http://www.cancer.org (last accessed 1 August 2017).

53.  Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol. 2008;58(suppl 2):S129-S132.

54.  Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila). 2010;3:233-245.

55.  Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA. 1996;276:972-977.

56.  Campbell RM, Perlis CS, Fisher E, et al. Gentamicin ointment versus petrolatum for management of auricular wounds. Dermatol Surg. 2005;31:664-669.

57.  Gette MT, Marks JG Jr, Maloney ME. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol. 1992;128:365-367.

58.  Suzuki H, Anderson RR. Treatment of melanocytic nevi. Dermatol Ther. 2005;18:217-226.

59.  Polder KD, Landau JM, Vergilis-Kalner IJ, et al. Laser eradication of pigmented lesions: a review. Dermatol Surg. 2011;37:572-595.

60.  Lee PK, Rosenberg CN, Tsao H, et al. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998;38:314-317.

61.  Gottschaller C, Hohenleutner U, Landthaler M. Metastasis of a malignant melanoma 2 years after carbon dioxide laser treatment of a pigmented lesion: case report and review of the literature. Acta Derm Venereol. 2006;86:44-47.

62.  Woodrow SL, Burrows SN. Malignant melanoma occurring at the periphery of a giant congenital naevus preciously treated with laser therapy. Br J Dermatol. 2003;149:886-888.

63.  Dummer R, Kempf W, Burg G. Pseudo-melanoma after laser therapy. Dermatology. 1998;197:71-73.

64.  Elder DE, Elenitsas R, Johnson BL, eds. Lever's histopathology of the skin. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.

65.  Cancer Research UK. Skin cancer statistics - key facts. May 2012. http://www.cancerresearchuk.org (last accessed 1 August 2017).

66.  Herzog C, Pappo A, Bondy M, et al. Malignant melanoma. In: Bleyer A, O'Leary M, Barr R, et al, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, MD: National Cancer Institute; 2006:53-64.

67.  Vourc'h-Jourdain M, Martin L, Barbarot S; aRED. Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review. J Am Acad Dermatol. 2013;68:493-498.

68.  Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol. 2001;45:260-276.

69.  Clark WH Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: 'the B-K mole syndrome'. Arch Dermatol.1978;114:732-738.

70.  Tsao H, Sober AJ, Niendorf KB, et al. Case records of the Massachusetts General Hospital: a 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma. N Engl J Med. 2004;350:924-932.

71.  de Maleissye MF, Beauchet A, Saiag P, et al. Sunscreen use and melanocytic nevi in children: a systematic review. Pediatr Dermatol. 2013;30:51-59.

72.  Crane LA, Deas A, Mokrohisky ST, et al. A randomized intervention study of sun protection promotion in well-child care. Prev Med. 2006;42:162-170.

73.  Menzies SW. Is sun exposure a major cause of melanoma? Yes. BMJ. 2008;337:a763.

74.  Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations - US surveillance, epidemiology, and end results (SEER) program, 1992 to 2001. Arch Dermatol. 2005;141:477-481.

75.  Shuster S. Is sun exposure a major cause of melanoma? No. BMJ. 2008;337:a764.

76.  Wernli KJ, Henrikson NB, Morrison CC, et al. Screening for skin cancer in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316:436-447.

使用此内容应接受我们的免责声明